Baxalta and Momenta target AbbVie’s blockbuster with positive biosim data

Damian Garde

Partners and Pharmaceuticals, among the many contenders looking to challenge the world's top-selling drug, posted for their take on AbbVie's Humira with hopes of launching a competitor in 2018.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS